Skip to main content

Financial Statements

Notes 6-10

8 PROPERTY, PLANT AND EQUIPMENT

Land and
buildings
$m
Plant and
equipment
$m
Assets in course
of construction
$m
Total property,
plant and
equipment
$m
Cost
At 1 January 2005 4,801 9,082 767 14,650
Capital expenditure 13 150 669 832
Transfer of assets into use 257 594 (851)
Disposals and other movements (99) (820) (14) (933)
Exchange adjustments (482) (971) (91) (1,544)
At 31 December 2005 4,490 8,035 480 13,005
Capital expenditure 23 196 577 796
Additions through business combinations 26 26
Transfer of assets into use 154 494 (648)
Disposals and other movements (35) (300) (3) (338)
Exchange adjustments 450 912 57 1,419
At 31 December 2006 5,082 9,363 463 14,908
Capital expenditure 53 304 812 1,169
Additions through business combinations 302 122 176 600
Transfer of assets into use 151 470 (621)
Disposals and other movements (23) (555) (16) (594)
Exchange adjustments 254 470 28 752
At 31 December 2007 5,819 10,174 842 16,835
Depreciation
At 1 January 2005 1,360 5,193 6,553
Charge for year 166 799 965
Impairment 90 90
Disposals and other movements (53) (794) (847)
Exchange adjustments (153) (588) (741)
At 31 December 2005 1,320 4,700 6,020
Charge for year 203 747 950
Impairment 6 47 53
Disposals and other movements (21) (277) (298)
Exchange adjustments 148 582 730
At 31 December 2006 1,656 5,799 7,455
Charge for year 227 849 1,076
Impairment 39 65 2 106
Disposals and other movements (3) (498) (1) (502)
Exchange adjustments 96 306 402
At 31 December 2007 2,015 6,521 1 8,537
Net book value
At 31 December 2005 3,170 3,335 480 6,985
At 31 December 2006 3,426 3,564 463 7,453
At 31 December 2007 3,804 3,653 841 8,298

Impairment charges in 2007 are attributable to the productivity initiatives in the global supply chain in Germany and the write-down of business support assets. These costs were recognised in cost of sales and general and administrative expenses in the income statement.

Impairment charges in 2006 are attributable to the write-down of assets in relation to the termination of NXY-059 and the write-down of assets in association with Toprol-XL, resulting from the introduction of generic competition in the US. The charges were recognised in cost of sales in the income statement.

Impairment charges in 2005 relate to the write-down of assets associated with capacity reviews at manufacturing sites, primarily in the UK and France. These were recognised in cost of sales in the income statement.

2007
$m
2006
$m
2005
$m
The net book value of land and buildings comprised:
Freeholds 3,804 3,421 3,164
Short leases 5 6
3,804 3,426 3,170
Back to top ↑